Africa: U.S. Drug Company Eases Access to Multidrug-Resistant Tuberculosis Treatment

[JNJ] Company continues to be focused on addressing perceived barriers to access and refocusing global efforts on the most-pressing barrier to access: underdiagnosis of the disease.
Source: AllAfrica News: Health and Medicine - Category: African Health Tags: Africa Economy, Business and Finance Company News External Relations Health and Medicine Tuberculosis United States, Canada and Africa Source Type: news